Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07340788 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Amylin-Induced Migraine Attacks Without Aura

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Pramlintide is a peptide analogue of human amylin which is a vasoactive signaling molecule involved in the pathogenesis of migraine. This study investigates whether pramlintide induces migraine attacks without aura in people with migraine without aura.
Trial Details
NCT Number NCT07340788
Lead Sponsor Danish Headache Center
Conditions
(from sponsor)		 Headache Disorders, Primary, Headache Disorders, Brain Diseases, Nervous System Diseases, Central Nervous System Diseases, Neurologic Manifestations, Signs and Symptoms, Pathological Conditions, Signs and Symptoms +10 more
Related terms Brain Diseases, Central Nervous System Diseases, Headache, Headache Disorders, Headache Disorders, Primary, Migraine Disorders, Nervous System Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov